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Summary We observed late stent thrombosis image by optical coherence tomography (OCT)
in vessels with off-label paclitaxel-eluting stents (PES) implantation. A 59-year-old Japanese
man was treated with a single on-label PES for chronic coronary artery disease in the left
circumﬂex artery. After 9 months, he was implanted with two linked PESs in the left anterior
descending artery (LAD) and a single PES in the right coronary artery (RCA). He was examined
for suspicion of a colon tumor by ﬁberscope after discontinuation of dual anti-platelet therapy
without consultation. He complained of chest pain and was transferred to our center. Emergency
coronary angiography demonstrated thrombotic total occlusion of the proximal LAD in the two
linked PESs. After thrombus aspiration therapy, OCT was performed to evaluate the stents in the
3 vessels. The off-label two linked PESs demonstrated the same average neo-intimal hyperplasia
(NIH) thickness and percentage of uncovered stent struts compared with the on-label PES in
the RCA by visualized OCT image. However, the heterogeneity of NIH in the LAD stent was
signiﬁcantly higher than the stents in the other two vessels. The implantation of the two linked
off-label and the heterogeneity of NIH may increase hyperplatelet coagulability more than
on-label single PES use.
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e observed late stent thrombosis (LST) image by opti-
al coherence tomography (OCT) in a vessel with off-label
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Figure 1 Optical coherence tomography (OCT) image of left anterior descending artery (LAD) after aspiration therapy. OCT
was performed to evaluate in-stent occlusion from the distal portion to the proximal portion in the LAD after aspiration therapy.
Serial OCT images showed in-stent long white thrombus images from the distal portion to the proximal portion. We analyzed the
representative in-stent thrombus image in the LAD. The signal intensity of half the distance of the thrombus was 134m (OCT image
5), 999m (OCT image 6), 339m, and 578m (OCT image 7) in the representative LAD stent thrombus. The in-stent thrombus
images were mainly compatible with white thrombus. OCT imaging was performed during occlusion of the proximal coronary artery
with a compliant balloon (4F occlusion balloon catheter; Helios®; LightLab Imaging, Westford, MA, USA) and continuous ﬂushing.
Fluid ﬂush was a mixture of one part Dextran 40 to three parts lactated Ringer’s solution. A 0.016-in. OCT catheter used an Image
wire® (LightLab Imaging). PES, paclitaxel-eluting stent.
Figure 2 Optical coherence tomography (OCT) 3-vessel study at follow up. 3-vessel OCT images after 4 weeks. OCT imaging was
performed during occlusion of the proximal coronary artery with a compliant balloon and continuous ﬂushing in the left circumﬂex
artery and right coronary artery. In the left anterior descending artery image, OCT imaging was performed without an occlusion
balloon because moderate plaque was observed in the proximal lesion. A 0.016-in. OCT catheter used an Image wire®. A 0.016-in.
OCT catheter, compliant balloon and OCT system was used. PES, paclitaxel-eluting stent.
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Figure 3 3-Vessel optical coherence tomography (OCT) assessment. OCT assessment of the average neo-intimal hyperplasia (NIH)
thickness (A), percentages of uncovered and malapposed stent struts (B), average lumen area (C) and heterogenicity of NIH (D).
OCT images were obtained for each 1mm in the stent. Numbers in (A), (B), and (D) show observed stent struts. Numbers in (C) show
OCT slice numbers. The average thickness of NIH was 0.075± 0.14mm for the paclitaxel-eluting stent (PES) in the left anterior
descending artery (LAD), 0.088± 0.10mm for the PES in the right coronary artery (RCA), and 0.095± 0.09mm for the PES in the
left circumﬂex artery (LCX) (p = 0.14). The percentage of uncovered stent struts in the LAD stent and the RCA stent were 19.1% and
18.2%, respectively, by OCT evaluation, whereas the percentage of uncovered stent struts in the LCX stent was 9.2% (p = 0.006).
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area was signiﬁcantly smaller in the LCX stent (3.4± 0.84mm2)
p < 0.0001).
paclitaxel-eluting stent (PES) implantation compared with
on-label stenting.
Case report
A 59-year-old Japanese man was treated with a single PES
(2.5/20mm) for chronic coronary artery disease at another
institute 18 months previously in the left circumﬂex artery
(LCX). Moreover, he was implanted with two linked PESs
(2.5/20mm and 2.75/20mm) in the left anterior descending
artery (LAD) and a single PES (3.5/20mm) in the right coro-
nary artery (RCA) at another institute 9 months previously.
After PES implantation, he was taking 200mg of aspirin and
200mg of ticlopidine.
He was examined for suspicion of a colon tumor by
colon ﬁberscope after discontinuation of dual anti-platelet
therapy for 6 days without consultation with a cardiolo-
gist in another private gastrointestinal clinic. Just after
colon ﬁber examination, he complained of severe chest
pain with ST elevation in the V1—V5 leads. He was trans-
ferred to our center with a diagnosis of acute myocardial
s
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aher than in the other two vessels, whereas the average lumen
in the other vessels (RCA; 8.0± 1.1mm2, LAD; 5.0± 0.85mm2,
nfarction. Emergency coronary angiography demonstrated
hrombotic total occlusion of the proximal LAD in the two
inked PESs. However, no thrombus images were conﬁrmed
n the RCA or LCX. Thrombus aspiration therapy was per-
ormed to the LAD thrombotic occlusion. Thrombolysis in
yocardial infarction-3 coronary reperfusion was obtained
fter the aspiration therapy. After the reperfusion, OCT
as performed to evaluate in-stent occlusion from the dis-
al portion to the proximal portion in the LAD. Thrombus
mages visualized by OCT were processed and analyzed with
IH image J (National Institutes of Health, Bethesda, MD,
SA). The signal intensity of half the distance of the throm-
us was 134m (Fig. 1, OCT image 5), 999m (OCT image
), 339m, and 578m (OCT image 7) in the representa-
ive LAD stent thrombus [1]. The in-stent thrombus images
ere mainly compatible with white thrombus. Moderate
eo-initimal hyperplasia (NIH) tissue was observed at the in-
tent proximal site. Moreover, 3-vessel OCT was performed
or evaluation of the PESs after 4 weeks (Fig. 2). OCT images
or evaluation of NIH of the 3 vessels were each captured at
n interval of 1mm. OCT analysis was performed by a skilled
nalyst. The percentage of uncovered and malapposed stent
es
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truts in the LAD stent and RCA stent were 19.1% and 18.2%,
espectively, whereas the percentage in the LCX stent were
.2% (Fig. 3B; p = 0.006). We compared the heterogeneity of
IH using the absolute value of NIH thickness on the stent
trut with the vertical line, and calculated the heterogeneity
f NIH thickness by an F-test. Heterogeneity of NIH thickness
n the LAD stent was signiﬁcantly higher than in the other
wo vessels. However, the average vessel lumen area was sig-
iﬁcantly smaller in the LCX stent than in the other vessels
Fig. 3).
iscussion
umen area just after stenting is an important factor for
ong-term restenosis and stent thrombosis [2]. LST occurred
n our case in the LAD stent, whereas the percentage of
ncovered and malapposed stent strut was equal to the
CA stent, and the lumen area in the LCX stent was signif-
cantly smaller than in the other two stents. Off-label uses
f PESs include multiple-stenting, overlapping stents, and
thers based on US Food and Drug Administration (FDA) rec-
mmendations [3]. Win et al. reported that major adverse
ardiac events, including stent thrombosis, in off-label use
f drug eluting stents (DES) occur signiﬁcantly more fre-
uently than with on-label use [4]. Accordingly, the FDA
ecommends avoiding off-label use of DES [3]. Moreover,
akakibara et al. reported that unevenness of lumen sur-
ace after stent implantation provokes platelet activation
nd aggregation [5]. In summary, the reasons for LST occur-
ing in the LAD stent are as follows: two stents used, a higher
ncovered and malapposed rate, the lumen area in the LAD
tent was smaller than in the RCA stent, a higher NIH het-
rogeneity than in the other stents, and discontinuation of
ual anti-platelet therapy.
[H. Matsui et al.
We felt that there were several study limitations in this
eport. First, in our case, the two linked PESs in the LAD
ave no overlapping site, but no gap (i.e. two stents were
mplanted side by side) visualized by OCT. It is unclear
hether overlapping stents have adverse effects from this
ase. Second, it is difﬁcult to distinguish between the
esidual organized small thrombus burden formed by neo-
ntima-like tissue and neo-intima tissue by OCT.
Implantation of two linked PESs and a higher heterogene-
ty of NIH may cause more hyperplatelet coagulability than
n-label single PES use. Continuation of dual anti-platelet
herapy may be especially important in patients with off-
abel use.
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